HIGH confidence: 100% data completeness across all factors and the composite score (26) is in decisive short territory. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $62M— | $211M+239.0% | $245M+15.9% | $436M+78.3% | $602M+38.0% |
| EPS (dil.) | $-0.26— | $-0.29n/m | $-0.38n/m | $-0.38n/m | $-0.37n/m |
| Free Cash Flow | -$97M— | -$149Mn/m | -$154Mn/m | -$116Mn/m | -$322Mn/m |
| Gross Margin | -3.0% | 9.0%+12.0pp | 21.0%+12.0pp | 26.6%+5.6pp | 34.4%+7.8pp |
| Operating Margin | -164.0% | -64.1%+99.9pp | -72.7%-8.7pp | -43.5%+29.2pp | -38.0%+5.5pp |
| Net Margin | -188.5% | -64.4%+124.1pp | -74.6%-10.2pp | -43.6%+31.0pp | -32.9%+10.7pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Avg target $100 (last qtr, 7 analysts) → $102 (last mo, 3) (+1.7%).
Buy-rated share 78% → 82% over ~3 months (+4pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $-0.06 | $-0.08 | -37.2% |
| May 2026 | $-0.07 | $-0.02 | +70.2% |
| Feb 2026 | $-0.10 | $-0.09 | +8.9% |
| Nov 2025 | $-0.10 | $0.01 | +110.1% |
| Aug 2025 | $-0.10 | $-0.10 | -5.0% |
| May 2025 | $-0.11 | $-0.12 | -12.6% |
| Feb 2025 | $-0.09 | $-0.10 | -11.1% |
| Nov 2024 | $-0.11 | $-0.10 | +9.1% |
Net insider -$361.6M over 180 days (0 open-market buys, 83 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
The QScore of 26 indicates a relatively weak assessment of RKLB, driven down by low scores in Value, Profitability, and Risk, which reflect the stock's high valuation metrics, such as a P/E of -197.6 and P/B of 9.9, as well as negative profitability metrics like an ROE of -7.6% and operating margin of -29.1%. The Growth category scores relatively high at 63, driven by 38% revenue growth, but this is offset by the stock's poor momentum, with a 12-month return of -17.3% and a bearish 50-day versus 200-day moving average trend. The long-term and short-term scores are relatively aligned, with only a 3-point difference.